Therapeutic Effect of Nile Tilapia Type II Collagen on Rigidity in CD8
cytokines
immune tolerance
molecular structure
type II collagen
Journal
Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357
Informations de publication
Date de publication:
22 Mar 2022
22 Mar 2022
Historique:
received:
25
01
2022
revised:
28
02
2022
accepted:
16
03
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
Fibrillins are microfibril-associated macro glycoproteins found in connective tissues and structurally related to latent TGF-β-binding proteins (LTBPs). The special cellular immunity and blocking glycoprotein receptors IIb and IIIa of fibrillins are emerging topics in recent years. In this study, Nile Tilapia type IIcollagen (NTCII) was extracted and purified from the skull cartilages by a pepsin-soluble method. Amino acid analysis indicated that NTCII consisted of 315/1000 glycine residues, 72/1000 hydroxyproline residues and 108/1000 proline residues. SDS-PAGE analysis showed that NTCII was composed of three identical 130 kDa α-chains. The results of glycoprotein/carbohydrate assay indicated that the total polysaccharide content of NTCII was 5.6-19.0%. The IR spectrum of NTCII displayed five characteristic peaks of amide I, II, III, A, B. NTCII at 10-100 μg/mL concentration downregulated the content of cytokines in the presence or absence of LPS, especially the secretion of cytokines IL-6, IL-1β and TNF-α. Interestingly, NTCII promoted the secretion of Fas/Apo-1 compared to the control group and 25 μg/mL of NTCII resulted in a higher Fas/Apo-1 secretion level in CD8
Identifiants
pubmed: 35406158
pii: polym14071284
doi: 10.3390/polym14071284
pmc: PMC9003223
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Allergy. 2016 May;71(5):720-3
pubmed: 26785247
Mar Drugs. 2018 Sep 25;16(10):
pubmed: 30257422
Pharmaceuticals (Basel). 2012 Mar 28;5(4):339-52
pubmed: 24281405
Science. 1993 Sep 24;261(5129):1727-30
pubmed: 8378772
Chest. 2010 Aug;138(2):363-70
pubmed: 20418369
Chin J Nat Med. 2014 Sep;12(9):712-20
pubmed: 25263986
Mar Drugs. 2014 Jun 27;12(7):3852-73
pubmed: 24979271
Matrix Biol. 2014 Feb;34:105-13
pubmed: 24113490
Inflamm Res. 2010 May;59(5):369-77
pubmed: 19862478
Int J Biol Macromol. 2018 Jan;106:544-550
pubmed: 28811205
Int J Colorectal Dis. 2010 Sep;25(9):1055-62
pubmed: 20571813
Cell. 1994 Jan 28;76(2):263-74
pubmed: 8293463
Autoimmunity. 1993;16(3):189-99
pubmed: 8003614
Am J Pathol. 1996 Dec;149(6):1971-9
pubmed: 8952532
Food Chem. 2020 Nov 30;331:127340
pubmed: 32569971
Int J Biol Macromol. 2015 Nov;81:220-7
pubmed: 26254247
J Immunol. 2002 Feb 1;168(3):977-80
pubmed: 11801627
J Immunol. 1998 Nov 15;161(10):5303-12
pubmed: 9820503
J Food Biochem. 2019 Nov;43(11):e13013
pubmed: 31407365
Int J Clin Pharmacol Res. 2002;22(3-4):101-10
pubmed: 12837047
J Exp Med. 1997 Jun 16;185(12):2133-41
pubmed: 9182685
J Exp Med. 1995 Jul 1;182(1):261-6
pubmed: 7540654
Int Immunopharmacol. 2020 Jun;83:106387
pubmed: 32172207
Arthritis Rheum. 1982 Mar;25(3):266-73
pubmed: 7039630
J Clin Invest. 1978 Jan;61(1):89-96
pubmed: 618915
Osteoarthritis Cartilage. 2017 Dec;25(12):2080-2090
pubmed: 28888901
Food Chem. 2018 Mar 1;242:568-578
pubmed: 29037731
Clin Immunol. 2007 Jan;122(1):75-84
pubmed: 17045846
Science. 1998 Aug 28;281(5381):1312-6
pubmed: 9721091
Int Immunopharmacol. 2011 Jan;11(1):12-8
pubmed: 20955833
Eur J Pharm Biopharm. 1998 Mar;45(2):113-36
pubmed: 9704909
Am J Med Sci. 2004 Apr;327(4):202-11
pubmed: 15084916